Local view for "http://purl.org/linkedpolitics/eu/plenary/2001-06-12-Speech-2-284"
| Predicate | Value (sorted: default) |
|---|---|
| rdf:type | |
| dcterms:Date | |
| dcterms:Is Part Of | |
| dcterms:Language | |
| lpv:document identification number |
"en.20010612.12.2-284"2
|
| lpv:hasSubsequent | |
| lpv:speaker | |
| lpv:translated text |
"The EU action plan for drugs for the years 2000–2004 has been drawn up on the basis of debates at the Second Interinstitutional Conference on Drugs Policy in Europe which was held in Brussels in February 2000 and the EU Drugs Strategy which the European Council supported at its Summit in Helsinki in December 1999. This action plan was also supported by the European Council at its Summit in Feira in Portugal in June 2000. In this action plan, which is now being implemented, the Commission is urged to work with Member States to draw up a procedure for voluntary monitoring of non-scheduled chemical precursors of synthetic drugs in partnership with the chemicals industry.
The Commission is also urged to regularly report to the Council on the control of diverting illicit chemical precursors, measures which have been implemented in the previous year and measures which are proposed for the coming year.
On the basis of the Commission’s proposals, on 5 June 2001 the Council adopted a regulation
amending the previous regulation laying down measures to be taken to discourage the diversion of certain substances to the illicit manufacture of narcotic drugs and psychotropic substances, to extend the definition of scheduled substances to natural products which contain such substances, extend the cooperation between Member State authorities and the chemicals industry to also cover non-scheduled substances and to give the Commission responsibility for drawing up guidelines to aid the chemical industry in achieving the aim of the aforementioned cooperation. These guidelines are to contain a regularly updated list of non-scheduled substances commonly used in the illicit manufacture of narcotic drugs and psychotropic substances, so that the industry will be able to monitor trade in such substances on a voluntary basis.
The EU is currently developing its activities in partnership chiefly with important countries of origin and transit countries in order to combat the illicit drug trade.
With regard to Latin America and the West Indies, the third top-level meeting within the framework of the cooperation and coordination mechanism has just started in Cochabamba in Bolivia. An action plan for the EU/Central Asia will be approved in the next few weeks. The fight against drugs has an important place in the partnership with the US within the framework of the Transatlantic Dialogue and with Russian within the framework of the Partnership and Cooperation Agreement. Within the preparations for the accession of candidate countries, the section of the Phare Programme addressing drugs is an important element of the fight against the drug trade. In addition, Europol has opened negotiations with 23 countries on entering into cooperation agreements. Most cooperation systems are concentrating on measures against illicit trade in drugs, seaways, control of synthetic drugs and increased police and customs cooperation."@en1
|
Named graphs describing this resource:
The resource appears as object in 2 triples